Dow Jones received a payment from EQS/DGAP to publish this press release.
EQS-News / 17/10/2017 / 09:29 UTC+8
*[FOR IMMEDIATE RELEASE]
/*
*Union Medical Healthcare Announces Sales Performance *
*during National Day Golden Week Holiday*
(16 October 2017, Hong Kong) *Union Medical Healthcare Limited* ("Union
Medical Healthcare" or the "Company"; together with its subsidiaries, the
"Group", SEHK stock code: 2138), a leading aesthetic medical service
provider in Hong Kong, announces today its sales performance during the
National Day Golden Week Holiday from 1 to 10 October 2017 (the "Period").
During the Period, the Company's unaudited cash sales recorded an increase
of approximately 25%, representing a significant increase of 78% compared
with the 14% growth for the same period last year.
*Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of
Union Medical Healthcare* said, "As the industry leader, Union Medical
Healthcare has been dedicating in expanding our scope of services for
diversity. The new business segment not only contributed to an increase in
our contracted sales, it also created a lot of cross sale opportunities for
our existing clients and new PRC clients. We will continue to look for
partnership in hotel accommodations, travel agencies and airlines to expand
our medical tourism business, which will serve as momentum for the Group's
business going forward."
- End -
*About Union Medical Healthcare Limited*
Union Medical Healthcare is principally engaged in the provision of one-stop
aesthetic medical, beauty and health management solutions with 46 clinics
and servicing centres across Hong Kong, the PRC and Macao as at 30 September
2017. In 2016, the Group obtained the Hong Kong Top Service Brand and opened
re:HEALTH, a one-stop health management centre, to provide a full range of
services and products, including comprehensive health screening, health
product and health management services. The Group is the largest aesthetic
medical service provider in Hong Kong in terms of revenue. The Group ranked
first in Hong Kong from 2012 to 2016 in terms of the number of aesthetic
injection procedures performed involving utilization of the top-six
revenue-generating aesthetic medications in Hong Kong; and was the Black
Diamond Provider of the transparent orthodontic device for teeth alignment,
Invisalign(R), in 2015 and 2016. The Group has successfully built DR REBORN,
a well-recognized brand in Hong Kong, with the reputation of being a premier
provider of aesthetic medical services in Hong Kong.
*For further information, please contact:
iPR Ogilvy & Mather*
Callis Lau / Molisa Lau / Maggie Chui / Francesca Yeung
Tel: (852) 2136 6952 / 2136 6953 / 2136 8059 / 3920 7639
Fax: (852) 3170 6606
Email: umh@iprogilvy.com
17/10/2017 Dissemination of a Financial Press Release, transmitted by EQS
Group.
The issuer is solely responsible for the content of this announcement.
Media archive at www.todayir.com
(END) Dow Jones Newswires
October 16, 2017 21:29 ET (01:29 GMT)
